Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1